Alterations in T Cell Subpopulations Linked to Brain Structure in Tardive Dyskinesia

Medically reviewed by Carmen Pope, BPharm. Last updated on July 25, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, July 25, 2024 -- Alterations in the proportion of T cell subpopulations are associated with brain structural abnormalities in patents with schizophrenia with tardive dyskinesia (TD), according to a study published in the July issue of Schizophrenia Research.

Na Li, from the Peking University HuiLongGuan Clinical Medical School in Beijing, and colleagues examined the correlations between distributions of T cell phenotypes and brain structure abnormalities in 50 schizophrenia patients with TD (TD) and 58 without TD (NTD), relative to 41 healthy controls (HC). Naive (CD45RA+), memory (CD45RO+), and apoptotic (CD95+) CD4+ and CD8+ T cells were examined by flow cytometry, as were the intracellular levels of cytokines in CD8+CD45RA+CD95+ and CD8+CD45RO+CD95+ T cells.

The researchers found that compared to the NTD and HC groups, the TD group had a higher percentage of CD8+CD45RO+CD95+ T cells, which correlated with the choroid plexus volume in the TD group. Associations were seen for the intracellular level of interferon-γ in CD8+CD45RO+CD95+ T cells, the fractional anisotropy (FA) of the fornix/stria terminalis, and the pallidum volume with orofacial TD, while correlations were seen for the fractional anisotropies of the inferior fronto-occipital fasciculus, cingulum, and superior longitudinal fasciculus with limb-truncal TD.

"These findings provide preliminary evidence that the association between immunosenescence-related T cell subpopulations and brain structure may underline the pathological process of TD," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords